Bernard Candas

5.7k total citations · 1 hit paper
74 papers, 4.2k citations indexed

About

Bernard Candas is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Bernard Candas has authored 74 papers receiving a total of 4.2k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Pulmonary and Respiratory Medicine, 21 papers in Genetics and 18 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Bernard Candas's work include Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Estrogen and related hormone effects (20 papers). Bernard Candas is often cited by papers focused on Prostate Cancer Treatment and Research (25 papers), Prostate Cancer Diagnosis and Treatment (22 papers) and Estrogen and related hormone effects (20 papers). Bernard Candas collaborates with scholars based in Canada, United States and France. Bernard Candas's co-authors include Fernand Labrie, Alain Bélanger, L. Cusan, José‐Luis Gomez, P. Diamond, Léonello Cusan, Claude Labrie, José L. Gómez, A. Bèlanger and Raul Suburu and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Endocrine Reviews.

In The Last Decade

Bernard Candas

72 papers receiving 4.0k citations

Hit Papers

Marked Decline in Serum Concentrations of Adrenal C19 Sex... 1997 2026 2006 2016 1997 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Marked Decline in Serum Concentrations of Adrenal C19 Sex Steroid Precursors and Conjugated Androgen Metabolites During Aging
    1997 552 citations Fernand Labrie, Alain Bélanger et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bernard Candas Canada 31 1.8k 1.5k 995 649 510 74 4.2k
David Crook United Kingdom 40 2.8k 1.5× 469 0.3× 1.5k 1.5× 461 0.7× 260 0.5× 147 5.7k
Olavi Ylikorkala Finland 44 1.6k 0.9× 304 0.2× 1.5k 1.6× 411 0.6× 395 0.8× 202 6.1k
Roger S. Rittmaster United States 52 3.4k 1.8× 3.5k 2.4× 810 0.8× 2.0k 3.1× 789 1.5× 144 9.2k
Matti Välimäki Finland 49 2.5k 1.4× 311 0.2× 595 0.6× 907 1.4× 1.3k 2.6× 159 6.3k
Joanne F. Dorgan United States 37 745 0.4× 468 0.3× 1.1k 1.1× 797 1.2× 1.6k 3.2× 99 4.4k
K. Bridget Brosnihan United States 44 3.2k 1.7× 288 0.2× 1.2k 1.2× 1.2k 1.8× 369 0.7× 89 7.4k
Y Kumahara Japan 38 2.5k 1.4× 287 0.2× 705 0.7× 1.2k 1.8× 314 0.6× 295 5.5k
Donna Shoupe United States 40 2.8k 1.5× 350 0.2× 2.5k 2.5× 283 0.4× 603 1.2× 123 6.5k
Harald Seeger Germany 39 1.0k 0.6× 353 0.2× 1.7k 1.7× 1.6k 2.5× 757 1.5× 236 4.9k
Sabina Rinaldi France 40 1.6k 0.9× 476 0.3× 842 0.8× 1.6k 2.5× 1.7k 3.2× 116 4.7k

Countries citing papers authored by Bernard Candas

Since Specialization
Citations

This map shows the geographic impact of Bernard Candas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard Candas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard Candas more than expected).

Fields of papers citing papers by Bernard Candas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard Candas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard Candas. The network helps show where Bernard Candas may publish in the future.

Co-authorship network of co-authors of Bernard Candas

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard Candas. A scholar is included among the top collaborators of Bernard Candas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard Candas. Bernard Candas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Guertin, Jason R., et al.. (2024). Evaluation and comparison of covariate balance metrics in studies with time‐dependent confounding. Statistics in Medicine. 43(23). 4437–4455.
2.
Sirois, Caroline, Jason R. Guertin, Mireille E. Schnitzer, et al.. (2024). Effect of statin use for the primary prevention of cardiovascular disease among older adults: a cautionary tale concerning target trials emulation. Journal of Clinical Epidemiology. 168. 111284–111284. 1 indexed citations
3.
Simard, Marc, et al.. (2024). A comparative analysis of medication counting methods to assess polypharmacy in medico-administrative databases. Research in Social and Administrative Pharmacy. 20(9). 905–910. 3 indexed citations
4.
5.
Roy, Denis, et al.. (2016). The Necessary – but Not Sufficient – Leadership of Research to Transform the Health Systems. A Nudge Too Far? A Nudge at All? On Paying People to Be Healthy. 16. 1 indexed citations
6.
Candas, Bernard, Gilles Jobin, Catherine Dubé, et al.. (2015). Barriers and facilitators to implementing continuous quality improvement programs in colonoscopy services: a mixed methods systematic review. SHILAP Revista de lepidopterología. 4(2). E118–E133. 13 indexed citations
7.
Gagnon, Marie‐Pierre, Bernard Candas, Marie Desmartis, et al.. (2014). Involving patient in the early stages of health technology assessment (HTA): a study protocol. BMC Health Services Research. 14(1). 273–273. 20 indexed citations
8.
Rothenmund, Heidi, Harminder Singh, Bernard Candas, et al.. (2013). Hereditary Colorectal Cancer Registries in Canada: Report from the Colorectal Cancer Association of Canada Consensus Meeting; Montreal, Quebec; October 28, 2011. Current Oncology. 20(5). 273–278. 5 indexed citations
9.
Labrie, Fernand, Léonello Cusan, José L. Gómez, et al.. (2004). Major impact of hormonal therapy in localized prostate cancer—death can already be an exception. The Journal of Steroid Biochemistry and Molecular Biology. 92(5). 327–344. 16 indexed citations
10.
Labrie, Fernand, Bernard Candas, L. Cusan, et al.. (2004). Screening decreases prostate cancer mortality: 11‐year follow‐up of the 1988 Quebec prospective randomized controlled trial. The Prostate. 59(3). 311–318. 137 indexed citations
11.
Labrie, Fernand, Léonello Cusan, José L. Gómez, et al.. (2003). De la biologie à la clinique : le décès dû au cancer de la prostate peut-il maintenant être une exception ?. médecine/sciences. 19(10). 910–919. 4 indexed citations
12.
Labrie, Fernand, Bernard Candas, José‐Luis Gomez, & Léonello Cusan. (2002). Can combined androgen blockade provide long-term control or possible cure of localized prostate cancer?. Urology. 60(1). 115–119. 76 indexed citations
13.
Labrie, Fernand, et al.. (2002). Effect of treatment sequence with radiotherapy and the antiestrogen EM 800 on the growth of ZR 75 1 human mammary carcinoma in nude mice. International Journal of Cancer. 103(2). 268–276. 4 indexed citations
14.
15.
Labrie, Fernand, Claude Labrie, A. Bélanger, et al.. (2001). Pure selective estrogen receptor modulators, new molecules having absolute cell specificity ranging from pure antiestrogenic to complete estrogen-like activities. Advances in protein chemistry. 56. 293–368. 20 indexed citations
16.
Labrie, Fernand, Bernard Candas, L. Cusan, et al.. (1999). Screening decreases prostate cancer death: First analysis of the 1988 Quebec Prospective Randomized Controlled Trial. The Prostate. 38(2). 83–91. 224 indexed citations
17.
18.
Martel, Céline, Claude Labrie, Alain Bélanger, et al.. (1998). Comparison of the Effects of the New Orally Active Antiestrogen EM-800 with ICI 182 780 and Toremifene on Estrogen-Sensitive Parameters in the Ovariectomized Mouse. Endocrinology. 139(5). 2486–2492. 30 indexed citations
19.
Labrie, Claude, et al.. (1998). Effect of Dehydroepiandrosterone and the Antiestrogen EM-800 on Growth of Human ZR-75-1 Breast Cancer Xenografts. JNCI Journal of the National Cancer Institute. 90(10). 772–778. 33 indexed citations
20.
Diamond, P., et al.. (1989). Trait anxiety, submaximal physical exercise and blood androgens. European Journal of Applied Physiology. 58(7). 699–704. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Crook Breakdown of academic impact, for papers by Olavi Ylikorkala Breakdown of academic impact, for papers by Roger S. Rittmaster Breakdown of academic impact, for papers by Matti Välimäki Breakdown of academic impact, for papers by Joanne F. Dorgan Breakdown of academic impact, for papers by K. Bridget Brosnihan Breakdown of academic impact, for papers by Y Kumahara Breakdown of academic impact, for papers by Donna Shoupe Breakdown of academic impact, for papers by Harald Seeger Breakdown of academic impact, for papers by Sabina Rinaldi
Rankless by CCL
2026